Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Astrazeneca (AZN) Share Price

Price 12,602.00p on 21-10-2026 at 12:00:40
Change -16.00p -0.13%
Buy 12,604.00p
Sell 12,602.00p
Add to Watchlist
Add to Portfolio
Add to Quickpicks
Last Trade: Sell 39.00 at 12,602.00p
Day's Volume: 435,322
Last Close: 12,618.00p
Open: 12,602.00p
ISIN: GB0009895292
Day's Range 12,536.00p - 12,646.00p
52wk Range: 11,404.00p - 15,730.00p
Market Capitalisation: £195.45b
VWAP: 12,601.88605p
Shares in Issue: 1.55b

Sector: Medicine and Biotech

Listed In: FTSE All-Share, FTSE All-Share ex Investment Trusts, FTSE Lower Yield, FTSE 350 ex Investment Trusts, FTSE 350 , FTSE 100,

Astrazeneca (AZN) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 39 12,602.00p Automatic Execution
 13:00:37 - 21-Oct-26
Sell* 20 12,602.00p Automatic Execution
 13:00:37 - 21-Oct-26
Sell* 26 12,602.00p Automatic Execution
 13:00:37 - 21-Oct-26
Sell* 13 12,602.00p Automatic Execution
 13:00:37 - 21-Oct-26
Sell* 27 12,602.00p Automatic Execution
 13:00:37 - 21-Oct-26
Sell* 19 12,602.00p Automatic Execution
 13:00:37 - 21-Oct-26
Sell* 1 12,602.00p Automatic Execution
 13:00:37 - 21-Oct-26
Sell* 58 12,602.00p Automatic Execution
 13:00:37 - 21-Oct-26
Sell* 40 12,604.00p Automatic Execution
 13:00:34 - 21-Oct-26
Sell* 20 12,604.00p Automatic Execution
 13:00:34 - 21-Oct-26
See more Astrazeneca trades

Astrazeneca (AZN) Share Price History

Time period:
to
Date Open High Low Close Volume
20th Oct 2026 (Tue) 12,440.00 12,626.00 12,388.00 12,618.00 4,421,942
19th Oct 2026 (Mon) 12,440.00 12,468.00 12,298.00 12,400.00 2,087,819
16th Oct 2026 (Fri) 12,506.00 12,576.00 12,420.00 12,446.00 2,900,609
15th Oct 2026 (Thu) 12,396.00 12,806.00 12,334.00 12,698.00 5,441,321
14th Oct 2026 (Wed) 11,820.00 12,328.00 11,816.00 12,300.00 2,181,667
13th Oct 2026 (Tue) 12,170.00 12,310.00 11,884.00 11,896.00 2,152,002
12th Oct 2026 (Mon) 12,038.00 12,076.00 11,916.00 12,026.00 1,750,925
9th Oct 2026 (Fri) 12,024.00 12,112.00 11,982.00 11,998.00 4,463,681
8th Oct 2026 (Thu) 12,032.00 12,124.00 11,890.00 11,892.00 2,276,534
7th Oct 2026 (Wed) 11,912.00 12,180.00 11,894.00 12,180.00 1,721,191
6th Oct 2026 (Tue) 11,904.00 12,108.00 11,782.00 11,958.00 2,188,384
5th Oct 2026 (Mon) 11,900.00 11,970.00 11,716.00 11,764.00 1,618,185
2nd Oct 2026 (Fri) 11,800.00 12,094.00 11,790.00 11,870.00 1,658,617
1st Oct 2026 (Thu) 12,014.00 12,200.00 12,011.00 12,032.00 3,716,388
30th Sep 2026 (Wed) 12,436.00 12,514.00 12,250.00 12,280.00 3,855,381
29th Sep 2026 (Tue) 12,526.00 12,786.00 12,386.00 12,428.00 2,734,917
28th Sep 2026 (Mon) 12,614.00 12,626.00 12,448.00 12,492.00 1,550,487
25th Sep 2026 (Fri) 12,400.00 12,614.00 12,398.00 12,552.00 1,735,427
24th Sep 2026 (Thu) 12,418.00 12,506.00 12,316.00 12,400.00 2,111,817
23rd Sep 2026 (Wed) 12,564.00 12,660.00 12,430.00 12,430.00 1,690,123
22nd Sep 2026 (Tue) 12,606.00 12,688.00 12,478.00 12,672.00 4,821,323
21st Sep 2026 (Mon) 12,450.00 12,630.00 12,364.00 12,560.00 3,916,309
See more Astrazeneca price history

Astrazeneca (AZN) Regulatory News

Date Source Headline
5th Oct 2026 12:00 pm RNS AstraZeneca completes equity investment in Summit
2nd Oct 2026 7:30 am RNS AZ & DS collaboration with Summit for Datroway
1st Oct 2026 3:05 pm RNS Admission of Further Securities to Trading
1st Oct 2026 3:00 pm RNS Total Voting Rights
29th Sep 2026 7:00 am RNS AstraZeneca announces equity investment in Summit
23rd Sep 2026 7:00 am RNS Trixeo approved in EU for asthma
21st Sep 2026 7:05 am RNS Klygefa recommended for EU approval by CHMP
21st Sep 2026 7:00 am RNS Enhertu recommended for approval in EU in early BC
18th Sep 2026 11:00 am RNS Director/PDMR Shareholding
15th Sep 2026 3:05 pm RNS Director/PDMR Shareholding
See more Astrazeneca regulatory news

Astrazeneca (AZN) Share News

Amgen and AstraZeneca celebrate positive Tezspire trial results in EoE

20th Oct 2026 15:00

(Alliance News) - Amgen Inc and AstraZeneca PLC on Tuesday hailed phase 3 trial results regarding their monoclonal antibody Tezspire, also known as tezepelumab. Read More

AstraZeneca and Oracle partner to advance AI in clinical trials

20th Oct 2026 11:34

(Alliance News) - AstraZeneca PLC and Oracle Corp on Tuesday announced a global collaboration to use artificial intelligence to improve clinical trials, patient diagnosis and treatment. Read More

WINNERS & LOSERS: Genuit falls on profit warning; Bunzl growth cools

20th Oct 2026 10:26

(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Tuesday. Read More

LONDON MARKET CLOSE: FTSE forges ahead but banks stutter on tax threat

16th Oct 2026 17:02

(Alliance News) - The FTSE 100 made further strong gains on Friday as Bank of England Governor Andrew Bailey played down inflation fears, although banks missed out amid fears of a tax hit. Read More

PRESS: UK government courted UBS over potential London move - FT

16th Oct 2026 13:33

(Alliance News) - The UK government has sought to persuade UBS Group AG to relocate its headquarters and stock market listing to London, as the Swiss banking giant considers its options amid tougher capital requirements in Switzerland, the Financial Times reported on Friday. Read More

See more Astrazeneca news
FTSE 100 Latest
Value10,738.94
Change5.94

Login to your account

Forgot Password?

Not Registered